There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...

What are the next steps for this research? I think the main question is, how does PSA-directed therapy and metastasis-directed therapy affect recurrent metastasis-free survival and survival outcomes ...

After hours: November 27 at 6:01 PM EST Loading Chart for PSA ...

The use of serum prostate-specific antigen (PSA) levels to screen for prostate cancer is controversial because of the difficulty in differentiating clinically insignificant cancers from those that ...

At close: November 27 at 4:00 PM EST ...

PSMA PET imaging shows a 35% positivity rate in prostate cancer patients with PSA levels below 0.5 ng/mL post-radical prostatectomy. Factors linked to suspicious PSMA activity include prior ...

An error occurred while fetching the data.

At close: 25 November at 16:00 GMT-5 ...

At close: November 19 at 4:00 p.m. EST ...

As of 10:56AM EST. Market open.